Featured Research

from universities, journals, and other organizations

Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids

Date:
August 9, 2012
Source:
American Roentgen Ray Society
Summary:
Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice –- hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile.

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice -hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile.

The study, conducted at the Yonsei University College of Medicine in Seoul South Korea, included 40 women with 10 cm or larger uterine fibroids. Twelve of the women received gonadotropin-releasing hormone (GnRH) agonists to shrink their fibroids before undergoing uterine artery embolization, said Man Deuk Kim, MD, PhD, lead author of the study. The remaining 28 patients underwent uterine artery embolization alone.

There has been disagreement over offering uterine artery embolization to women with fibroids larger than 10 cm in diameter because of concerns about an increased risk of infection or sepsis, said Dr. Kim. "Our study found that by adding GnRH agonists as part of treatment, the large fibroids shrunk by about 36% on average and complications were reduced," he said. Major complications requiring hospitalization for more than 48 hours were not seen in the group that had both GnRH agonists and uterine artery embolization, while four patients from the group that were treated with uterine embolization alone suffered complications that required 48 or more hours of hospitalization, Dr. Kim noted.

GnRH agonist treatment does tend to make the uterine arteries smaller and more prone to temporary, sudden narrowing, said Dr. Kim. "However, our study showed adding GnRH to treatment did not prevent uterine artery embolization in patients with large fibroids," he said.

All patients treated with GnRH agonists and uterine artery embolization had successful procedures with follow-up of patients showing complete necrosis of the fibroids. Twelve patients treated with uterine artery embolization had successful procedures, said Dr. Kim.

"When patients who have large fibroids greater than 10 cm come to me seeking an alternative to surgery, I counsel them to consider GnRH agonists plus uterine artery embolization as a treatment option. Interventional radiologists may be unfamiliar with prescribing GnRH, but our study encourages them to consider GnRH as a pretreatment for patients with large fibroids who want to avoid surgery."

The study was published in the August issue of the American Journal of Roentgenology.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. D. Kim, M. Lee, M. S. Lee, S. I. Park, J. Y. WonQ, D. Y. Lee, K. H. Lee. Uterine Artery Embolization of Large Fibroids: Comparative Study of Procedure With and Without Pretreatment Gonadotropin-Releasing Hormone Agonists. American Journal of Roentgenology, 2012; 199 (2): 441 DOI: 10.2214/AJR.11.7220

Cite This Page:

American Roentgen Ray Society. "Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids." ScienceDaily. ScienceDaily, 9 August 2012. <www.sciencedaily.com/releases/2012/08/120809133849.htm>.
American Roentgen Ray Society. (2012, August 9). Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids. ScienceDaily. Retrieved September 15, 2014 from www.sciencedaily.com/releases/2012/08/120809133849.htm
American Roentgen Ray Society. "Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids." ScienceDaily. www.sciencedaily.com/releases/2012/08/120809133849.htm (accessed September 15, 2014).

Share This



More Health & Medicine News

Monday, September 15, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins